Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhanced Extracellular Matrix Breakdown Characterizes the Early Distraction Phase of Canine Knee Joint Distraction. | Cartilage | 2021 | 34014119 | PubTator, text mining | PubMed |
| [Effects of bevacizumab on familial epistaxis caused by hereditary hemorrhagic telangiectasia]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2021 | 34010995 | PubTator, text mining | PubMed |
| Perianal Solitary Fibrous Tumor in a Rare Anatomical Presentation: A Case Report and Literature Review. | Am J Case Rep | 2021 | 34010267 | PubTator, text mining | PubMed |
| Exogenous BMP9 promotes lung fibroblast HFL-1 cell activation via ALK1/Smad1/5 signaling in vitro. | Exp Ther Med | 2021 | 34007337 | PubTator, text mining | PubMed |
| Dihydroartemisinin inhibits endothelial cell migration via the TGF-β1/ALK5/SMAD2 signaling pathway. | Exp Ther Med | 2021 | 34007318 | PubTator, text mining | PubMed |
| Next-generation sequencing revealed recurrent ZFPM1 mutations in encapsulated papillary carcinoma of the breast. | NPJ Precis Oncol | 2021 | 34007008 | PubTator, text mining | PubMed |
| Pathogenic ACVR1R206H activation by Activin A-induced receptor clustering and autophosphorylation. | EMBO J | 2021 | 34003511 | PubTator, text mining | PubMed |
| Primary bone anaplastic lymphoma kinase positive anaplastic large-cell lymphoma: A case report and review of the literature. | World J Clin Cases | 2021 | 34002151 | PubTator, text mining | PubMed |
| EnRank: An Ensemble Method to Detect Pulmonary Hypertension Biomarkers Based on Feature Selection and Machine Learning Models. | Front Genet | 2021 | 33986767 | PubTator, text mining | PubMed |
| Deciphering Pharmacological Mechanism of Buyang Huanwu Decoction for Spinal Cord Injury by Network Pharmacology Approach. | Evid Based Complement Alternat Med | 2021 | 33976706 | PubTator, text mining | PubMed |
| ALK-Positive Histiocytosis: A Case Report and Literature Review. | Turk Patoloji Derg | 2021 | 33973641 | PubTator, text mining | PubMed |
| Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH. | Genome Med | 2021 | 33971972 | PubTator, text mining | PubMed |
| HTLV-1-Associated Lymphoma Presented as Massive Lymphadenopathy. | J Investig Med High Impact Case Rep | 2021 | 33969717 | PubTator, text mining | PubMed |
| Pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and family gene analysis: A case report. | World J Clin Cases | 2021 | 33969094 | PubTator, text mining | PubMed |
| Prognostic role of ALK-1 and h-TERT expression in glioblastoma multiforme: correlation with ALK gene alterations. | J Pathol Transl Med | 2021 | 33966367 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Case series: Inflammatory myofibroblastic bladder tumor in regional Australia. | Int J Surg Case Rep | 2021 | 33957398 | PubTator, text mining | PubMed |
| iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension. | Sci Transl Med | 2021 | 33952674 | PubTator, text mining | PubMed |
| Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report. | J Med Case Rep | 2021 | 33952307 | PubTator, text mining | PubMed |
| The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab. | J Cachexia Sarcopenia Muscle | 2021 | 33951326 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=61